Top Upgrades

  • Citigroup upgraded United Parcel Service, Inc. UPS from Neutral to Buy. UPS shares rose 1.11 percent to $113.10 in pre-market trading.
  • Drexel Hamilton upgraded L3 Technologies Inc LLL from Hold to Buy. L3 Technologies shares rose 0.33 percent to close at $176.58 on Monday.
  • Analysts at Mitsubishi UFJ upgraded Twilio Inc TWLO from Neutral to Overweight. Twilio shares rose 14.3 percent to $34.90 in pre-market trading.
  • Analysts at Argus upgraded Tesla Inc TSLA from Hold to Buy. Tesla shares rose 0.57 percent to $357.20 in pre-market trading.
  • Morgan Stanley upgraded Foot Locker, Inc. FL from Equal-Weight to Overweight. Foot Locker shares gained 3.40 percent to $50.50 in pre-market trading.
  • Analysts at Pivotal Research upgraded Discovery Communications Inc. DISCA from Hold to Buy. Discovery shares gained 2.19 percent to close at $24.25 on Monday.
  • Analysts at Berenberg upgraded Cognizant Technology Solutions Corp CTSH from Hold to Buy. Cognizant shares fell 2.23 percent to close at $69.59 on Monday.
  • Susquehanna upgraded Rapid7 Inc RPD from Neutral to Positive. Rapid7 shares rose 7.57 percent to $16.20 in pre-market trading.
  • JP Morgan upgraded Varex Imaging Corp VREX from Underweight to Neutral. Varex Imaging shares rose 0.07 percent to close at $28.27 on Monday.


Top Downgrades

  • Baird downgraded Plains All American Pipeline, L.P. PAA from Outperform to Neutral. Plains All American shares fell 14.68 percent to $21.50 in pre-market trading.
  • Maxim Group downgraded GW Pharmaceuticals PLC- ADR GWPH from Buy to Hold. GW Pharmaceuticals shares fell 4.60 percent to $109.80 in pre-market trading.
  • Analysts at JP Morgan downgraded Diebold Nixdorf Inc DBD from Overweight to Neutral. Diebold shares fell 0.89 percent to close at $22.35 on Monday.
  • Wedbush downgraded Beazer Homes USA, Inc. BZH from Outperform to Neutral. Beazer Homes shares rose 4.08 percent to close at $16.08 on Monday.
  • H.C. Wainwright downgraded Zynerba Pharmaceuticals Inc ZYNE from Buy to Neutral. Zynerba Pharmaceuticals shares declined 3.75 percent to $6.42 in pre-market trading.
  • Analysts at Jefferies downgraded NxStage Medical, Inc. NXTM from Buy to Hold. NxStage Medical shares fell 0.40 percent to $29.55 in pre-market trading.
  • Janney Capital downgraded Depomed Inc DEPO from Buy to Neutral. Depomed shares dropped 17.66 percent to $7.60 in pre-market trading.
  • SunTrust Robinson Humphrey downgraded National-Oilwell Varco, Inc. NOV from Hold to Sell. National Oilwell Varco shares declined 4.19 percent to close at $31.79 on Monday.
  • Deutsche Bank downgraded THL Credit, Inc. TCRD from Buy to Hold. THL Credit shares fell 1.22 percent to $9.75 in pre-market trading.


Top Initiations

  • Analysts at Morgan Stanley initiated coverage on Lockheed Martin Corporation LMT with an Overweight rating. The price target for Lockheed Martin is set to $342. Lockheed Martin shares closed at $297.15 on Monday.
  • Cowen & Co. initiated coverage on Akcea Therapeutics Inc AKCA with an Outperform rating. Akcea Therapeutics shares closed at $14.90 on Monday.
  • DA Davidson initiated coverage of Broadridge Financial Solutions, Inc. BR with a Neutral rating. The price target for Broadridge Financial is set to $74. Broadridge Financial shares closed at $75.60 on Monday.
  • Morgan Stanley initiated coverage on General Dynamics Corporation GD with an Underweight rating. The price target for General Dynamics is set to $185. General Dynamics shares closed at $201.14 on Monday.
  • Barclays initiated coverage on Brighthouse Financial Inc BHF with an Overweight rating. The price target for Brighthouse Financial is set to $72. Brighthouse Financial shares closed at $61.72 on Monday.
  • Analysts at Morgan Stanley initiated coverage on Northrop Grumman Corporation NOC with an Equal-Weight rating. The price target for Northrop Grumman is set to $279. Northrop Grumman shares closed at $269.58 on Monday.
  • Analysts at Stifel Nicolaus initiated coverage on Akcea Therapeutics Inc AKCA with a Buy rating. The price target for Akcea Therapeutics is set to $19. Akcea Therapeutics shares closed at $14.90 on Monday.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Comments
Loading...